A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial

Publication | Closed Access

DOI

Citations

References

2016

Year

Antoinette de Waha, Sigrid Sandner, Moritz von Scheidt, Andreas Boening, K. Koch-Buettner, Dieter Hammel, Rainer Hambrecht, Bernhard C. Danner, Friedrich A. Schöndube, G Goerlach,

American Heart Journal

ThrombosisVascular EventsCardiovascular DiseaseCoronary Artery DiseaseDouble-blind StudyVascular SurgeryCardiologyParallel GroupPharmacotherapyPlatelet AntagonistMedicineAtherosclerosisEmergency MedicineAnesthesiology